Cargando…
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis
Cancer aberrant N- and O-linked protein glycosylation, frequently resulting from an augmented flux through the Hexosamine Biosynthetic Pathway (HBP), play different roles in tumor progression. However, the low specificity and toxicity of the existing HBP inhibitors prevented their use for cancer tre...
Autores principales: | Ricciardiello, Francesca, Votta, Giuseppina, Palorini, Roberta, Raccagni, Isabella, Brunelli, Laura, Paiotta, Alice, Tinelli, Francesca, D’Orazio, Giuseppe, Valtorta, Silvia, De Gioia, Luca, Pastorelli, Roberta, Moresco, Rosa Maria, La Ferla, Barbara, Chiaradonna, Ferdinando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841296/ https://www.ncbi.nlm.nih.gov/pubmed/29515119 http://dx.doi.org/10.1038/s41419-018-0405-4 |
Ejemplares similares
-
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
por: Chiaradonna, Ferdinando, et al.
Publicado: (2018) -
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability
por: Chiaradonna, Ferdinando, et al.
Publicado: (2016) -
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells
por: Nobile, Marco S, et al.
Publicado: (2020) -
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor
por: Ricciardiello, Francesca, et al.
Publicado: (2021) -
Central metabolism of functionally heterogeneous mesenchymal stromal cells
por: Barilani, Mario, et al.
Publicado: (2019)